The construct is expressed in cultures of mouse myeloma ... multiple glycoforms [79]. CDR: Complementarity-determining variable region; CH1, CH2, CH3 and CL: Constant regions of IgG on light ...

Preventive IVIG therapy is recommended by numerous experts when the IgG level drops below 400 mg/dL ... For high-risk newly diagnosed patients with multiple myeloma (NDMM), additional treatment ...

In patients with non-IgM monoclonal proteins (such as IgG or IgA) detected in the serum or urine and kidney, therapy strategy akin to that used for multiple myeloma is used. For IgM monoclonal protein ...

Multiple myeloma (MM) is a type of blood cancer that typically has no cure. Treatments like medications and stem cell ...

Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated ...

Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed ...

A Boulder woman is opening up about her fight with multiple myeloma during Blood Cancer Awareness Month. She went from being ...

During a Case-Based Roundtable® event, Samer A. Al'Hadidi, MD, MS, discussed the CARTITUDE-4 trial of cilta-cel in patients with relapsed/refractory multiple myeloma in the first article of a 2-part ...

Multiple myeloma is a rarer disease than other cancers, such as lung or breast cancer, an expert told CURE®. During the CURE® Educated Patient® Multiple Myeloma Summit, patients asked some questions ...